Manager × security

HUDSON EDGE INVESTMENT PARTNERS INC. CVS holdings history

Who else holds this security? →

CVS HEALTH CORP · CUSIP 126650100 · CIK 740272

Some filings reported values in thousands; those figures were scaled ×1000 to dollars.
This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, HUDSON EDGE INVESTMENT PARTNERS INC. reported 76.63K CVS (shares), valued at $7.93M, or 1.08% of its reported non-derivative portfolio. Filed 2026-07-29.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
1.08%
Shares
76.63K
76,628
Reported value
$7.93M
USD

Shares decreased 26.93%; reported value increased 5.25%, and weight changed -0.02 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20261.08%76,628SEC filing ↗Filed Jul 29, 2026
Q1 20261.10%104,865SEC filing ↗Filed Apr 27, 2026
Q4 20251.11%94,175SEC filing ↗Filed Jan 27, 2026
Q3 20251.22%100,135SEC filing ↗Filed Oct 30, 2025
Q2 20251.18%100,135SEC filing ↗Filed Jul 21, 2025
Q1 20251.45%105,098SEC filing ↗Filed Apr 28, 2025
Q4 20240.88%105,791SEC filing ↗Filed Feb 3, 2025
Q3 20240.92%79,115SEC filing ↗Filed Oct 31, 2024
Q2 20240.92%80,985SEC filing ↗Filed Aug 6, 2024
Q1 20241.21%77,669SEC filing ↗Filed May 13, 2024
Q4 20231.32%71,841SEC filing ↗Filed Feb 13, 2024
Q3 20231.97%86,557SEC filing ↗Filed Oct 20, 2023

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q3 20231.97%86,557$6.04MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Oct 20, 2023
Q4 20231.32%71,841$5.67MShares decreased 17.00%; reported value decreased 6.13%, and weight changed -0.65 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 13, 2024
Q1 20241.21%77,669$6.19MShares increased 8.11%; reported value increased 9.21%, and weight changed -0.11 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 13, 2024
Q2 20240.92%80,985$4.78MShares increased 4.27%; reported value decreased 22.79%, and weight changed -0.29 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 6, 2024
Q3 20240.92%79,115$4.97MShares decreased 2.31%; reported value increased 4.01%, and weight changed +0.00 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Oct 31, 2024
Q4 20240.88%105,791$4.75MShares increased 33.72%; reported value decreased 4.54%, and weight changed -0.04 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 3, 2025
Q1 20251.45%105,098$7.12MShares decreased 0.66%; reported value increased 49.94%, and weight changed +0.57 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Apr 28, 2025
Q2 20251.18%100,135$6.91MShares decreased 4.72%; reported value decreased 2.99%, and weight changed -0.27 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jul 21, 2025
Q3 20251.22%100,135$7.55MShares unchanged; reported value increased 9.29%, and weight changed +0.04 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Oct 30, 2025
Q4 20251.11%94,175$7.47MShares decreased 5.95%; reported value decreased 1.00%, and weight changed -0.11 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jan 27, 2026
Q1 20261.10%104,865$7.53MShares increased 11.35%; reported value increased 0.77%, and weight changed -0.01 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Apr 27, 2026
Q2 20261.08%76,628$7.93MShares decreased 26.93%; reported value increased 5.25%, and weight changed -0.02 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jul 29, 2026
HUDSON EDGE INVESTMENT PARTNERS INC. · CVS HEALTH CORP

Take these holdings further.

This page includes 12 of 12 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"740272","quarter":"2026Q2","cusip":"126650100"}

get_institutional_manager_history
{"cik":"740272","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.